Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States
Lu Meng, Neil Chandra Murthy, Bhavini Patel Murthy, Elizabeth Zell, Ryan Saelee, Megan Irving, Hannah E. Fast, Patricia Castro Roman, Adam Schiller, Lauren Shaw, Carla L. Black, Lynn Gibbs-Scharf, LaTreace Harris, and Terence Chorba
Author affiliations: Centers for Disease Control and Prevention Atlanta, Georgia, USA (L. Meng, N.C. Murthy, B.P. Murthy, E. Zell, R. Saelee, M. Irving, H.E. Fast, P.Castro Roman, A. Schiller, L. Shaw, C.L. Black, L. Gibbs-Scharf, L. Harris, T. Chorba); General Dynamics Information Technology Inc., Falls Church, Virginia, USA (L. Meng, R. Saelee); Stat-Epi Associates, Inc., Ponte Vedra Beach, Florida, USA (E. Zell); Deloitte Consulting LLP, New York, New York, USA (M. Irving); Booz Allen Hamilton, Inc., McLean, Virginia, USA (A. Schiller)
Figure 1. Logistic regression models built to examine sociodemographic factors associated with missed or delayed second doses in primary series of mRNA COVID vaccination among persons >12 years of age, United States. The table at the top includes all records from initial query that met the inclusion criteria. The lower 2 sub-tables provide the number of records included in each of the 2 multivariable logistic regression models. Pfizer-BioNTech, https://www.pfizer.com; Moderna, https://www.modernatx.com.
Page created: June 22, 2022
Page updated: July 20, 2022
Page reviewed: July 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.